← Open Payments lookup

SAMANTHA BELLINGER: Open Payments

NPI 1275902900 · OKLAHOMA CITY, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$13,619 in 264 payments from 23 companies in 2025. Trend: 2023 $8,994 · 2024 $10,284 · 2025 $13,619

Food & beverage: $6,118Speaker / faculty: $4,988Consulting: $2,088Travel & lodging: $424
CompanyPaymentsAmount
GENZYME CORPORATION24$6,191
Regeneron Healthcare Solutions, Inc.24$3,038
AstraZeneca Pharmaceuticals LP37$1,003
Insmed, Inc.33$698
GlaxoSmithKline, LLC.30$428
United Therapeutics Corporation8$321
Pulmonx Corporation14$320
Amgen Inc.17$265
Boehringer Ingelheim Pharmaceuticals, Inc.13$237
Verona Pharma, Inc.19$226

Products named: DUPIXENT, Arikayce, FASENRA, TEZSPIRE, CHARTIS CATHETER, NUCALA, Ohtuvayre, Tyvaso.

Industry payments across OK — which companies pay providers there.